Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

Recruiting now · Not applicable

Conditions studied: Heart Failure, Diabetes

In brief

A pragmatic electronic health record (EHR) based randomized controlled trial to evaluate the utility of providing Ultromics EchoGo analysis results and recommendations for HF risk prevention therapies using an EHR embedded clinical decision support tool.

Key facts

Study ID

NCT06593314

Run by

University of Texas Southwestern Medical Center

People needed

800

Starts

2025-08-06

Expected to finish

2026-10-15

Last updated by the study team

2026-05-07

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with diagnosis of Type 2 diabetes and High WATCH DM score.
• Echocardiogram available in last 6-months.

You may not qualify if…

• History of HF
• Not eligible for prescription of new GLP-1RA or SGLT2i or ns-MRA
• Corresponding providers to patients identified by the above inclusion exclusion criteria will be included in the clinical trial of the decision support tool.

Where it is running

• UT Southwestern Medical Center — Dallas, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.